参考文献/References:
[1] Yokoseki A,Saji E,Arakawa M,et al.Hypertrophic pachymeningitis: significance of myeloperoxidase anti-neutrophil cytoplasmic antibody[J].Brain,2014,137(Pt 2):520-536.
[2]Bureta CA,Abematsu M,Tominaga H,et al.Hypertrophic spinal pachymeningitis associated with human T-cell lymphotrophic virus-1 infection and Sjogren's syndrome:A case report and brief literature review[J].Int J Surg Case Rep,2018,45:22-28.
[3]谢盈慧,刘诗群,丁莉,等.垂体炎合并肥厚性硬脑膜炎1例并文献复习[J].中国医刊,2017,52(2):36-41.
[4]沈遥遥,戴庭敏,涂江龙,等.结核性肥厚性硬脑膜炎1例报告[J].中国神经精神疾病杂志,2016,42(2):124-125.
[5]张丽华,王秀娟,林涛,等.类风湿关节炎并发肥厚性硬脑膜炎一例[J].中华临床免疫和变态反应杂志,2017,11(4):386-389.
[6]黄超,任向阳,马聪敏.不同病因的肥厚性硬脑膜炎临床及影像学特点分析[J].中国现代医药杂志,2017,19(11):61-62.
[7]De Virgilio A,De Vincentiis M,Inghilleri M,et al.Idiopathic hypertrophic pachymeningitis: an autoimmune IgG4-related disease[J].Immunol Res,2017,65(1, SI):386-394.
[8]Peng AQ,Yang XM,Wu WJ,et al.Anti-neutrophil cytoplasmic antibody-associated hypertrophic cranial pachymeningitis and otitis media: a review of literature[J].European Archives of Oto-Rhino-Laryngology,2018,275(12):2915-2923.
[9]Imafuku A,Sawa N,Kawada M,et al.Incidence and risk factors of new-onset hypertrophic pachymeningitis in patients with anti-neutrophil antibody-associated vasculitis: using logistic regression and classification tree analysis[J].Clin Rheumatol,2019,38(4):1039-1046.
[10]Kaga H,Komatsuda A,Saito M,et al.Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis Complicated by Periaortitis and Cranial Hypertrophic Pachymeningitis: A Report of an Autopsy Case[J].Internal Medicine,2018,57(1):107-113.
[11]Yonekawa T,Murai H,Utsuki S,et al.A nationwide survey of hypertrophic pachymeningitis in Japan[J].J Neurol Neurosurg Psychiatry,2014,85(7):732-739.
[12]Harabuchi Y,Kishibe K,Tateyama K,et al.Clinical features and treatment outcomes of otitis media with antineutrophil cytoplasmic antibody(ANCA)-associated vasculitis(OMAAV):A retrospective analysis of 235 patients from a nationwide survey in Japan[J].Mod Rheumatol,2017,27(1):87-94.
[13]范道丰,陈银娟,李洵桦,等.肥厚性硬脑膜炎19例临床分析[J].临床神经病学杂志,2018,31(5):372-375.
[14]崔晓萌.ANCA相关性血管炎研究进展[J].复旦学报:医学版,2018,45(3):423-427.
[15]Barbieri FR,Novegno F,Iaquinandi A,et al.Hypertrophic pachymeningitis and Hydrocephalus-The role of neuroendoscopy: case report and review of the literature[J].World Neurosurg,2018,119:183-188.
[16]Ito F,Kondo N,Fukushima S,et al.Catatonia induced by idiopathic hypertrophic pachymeningitis[J].Gen Hosp Psychiatry,2010,32(447):e7-447.
[17]郑国庆,王小同.特发性肥厚性硬脑膜,脊膜炎[J].医师进修杂志:内科版,2004,27(13):53-55.
[18]Di SV,Dono F,De Angelis MV,et al.Hypertrophic pachymeningitis and cerebral venous thrombosis in myeloperoxidase-ANCA associated vasculitis[J].BMJ Case Rep,2019,12(1):226780.
[19]Chen H,Zhang W,Jing J,et al.The clinical and imaging features of hypertrophic pachymeningitis: a clinical analysis on 22 patients[J].Neurological Sciences,2019,40(2):269-274.
[20]Skierczynski PA,Goodman JM,Signal P,et al.Idiopathic hypertrophic pachymeningitis resulting in delayed panhypopituitarism[J].Endocr Pract,2007,13(5):481-486.
[21]沈桂芬,雷小妹,胡绍先,等.抗髓过氧化物酶中性粒细胞胞质抗体相关性肥厚性硬脑膜炎1例报告及文献复习[J].解放军医学院学报,2016,37(9):1004-1007.
[22]Popkirov S,Kowalski T,Schlegel U,et al.Immunoglobulin-G4-related hypertrophic pachymeningitis with antineutrophil cytoplasmatic antibodies effectively treated with rituximab[J].Journal of Clinical Neuroscience,2015,22(6):1038-1040.
[23]Shimojima Y,Kishida D,Sekijima Y.Increased BAFF and April levels in the cerebrospinal fluid of patients with anti-neutrophilcytoplasmic antibody-related hypertrophic pachymeningitis[J].Cytokine,2017,99:305-309.
[24]赵鹏,张本恕.核周型-抗中性粒细胞胞质抗体相关性肥厚性硬脑膜炎临床分析[J].中华医学杂志,2013,93(11):837-840.
[25]Kaieda S,Yoshida N,Minezaki M,et al.The successful treatment of myeloperoxidase antineutrophil cytoplasmic antibody-positive hypertrophic pachymeningitis in patients with the limited form of granulomatosis with polyangiitis using methotrexate: two case reports[J].Internal Medicine,2017,56(8):959-965.
[26] Culbertson CJ,Lummus SC,Gold CA.Teaching NeuroImages: myeloperoxidase-anti-neutrophil cytoplasmic antibody-positive hypertrophic pachymeningitis[J].Neurology,2017,89(21):E253.
[27] Sharma A,Kumar S,Wanchu A,et al.Successful treatment of hypertrophic pachymeningitis in refractory Wegener's granulomatosis with rituximab[J].Clin Rheumatol,2010,29(1):107-110.
[28] Suarez AR,Capote AC,Yf B,et al.Ocular involvement in idiopathic hypertrophic pachymeningitis associated with eosinophilic angiocentric fibrosis:a case report[J].Arq Bras Oftalmol,2018,81(30):250-253.